All Clinical Resources

1 - 2 of 2 results
lipoprotein cell close up

Lipoprotein(a) Learning Module

An Adaptive Learning Experience Sponsored by Novartis Pharmaceuticals Corporation; Not for CME/CE CreditThis course is hosted by an external partner. By clicking Launch Course, you will be directed off of Pri-Med.com. Upon completing the activity, you will be prompted to return to Pri-Med.com

Lipoprotein(a) is a genetically determined LDL-C like particle that is uniquely proatherogenic, prothrombotic, and proinflammatory. While emerging therapies are on the horizon, there are no current FDA approved medicinal treatment options for Lp(a). Understanding the prevalence and need to test for Lp(a) will help your patients mitigate potential cardiovascular risks via lifestyle modification and informing clinical practice. This interactive module will cover: • The differences between LDL-C and Lp(a) • Testing and incidence of Lp(a), as well as associated diseases • Cardiovascular risk and risk-enhancing factors that can lead to cardiovascular events • Lifestyle management and risk factor mitigation


lipoprotein cell close up

Lipoprotein(a) Learning Module

An Adaptive Learning Experience Sponsored by Novartis Pharmaceuticals Corporation; Not for CME/CE CreditThis course is hosted by an external partner. By clicking Launch Course, you will be directed off of Pri-Med.com. Upon completing the activity, you will be prompted to return to Pri-Med.com

Lipoprotein(a) is a genetically determined LDL-C like particle that is uniquely proatherogenic, prothrombotic, and proinflammatory. While emerging therapies are on the horizon, there are no current FDA approved medicinal treatment options for Lp(a). Understanding the prevalence and need to test for Lp(a) will help your patients mitigate potential cardiovascular risks via lifestyle modification and informing clinical practice. This interactive module will cover: • The differences between LDL-C and Lp(a) • Testing and incidence of Lp(a), as well as associated diseases • Cardiovascular risk and risk-enhancing factors that can lead to cardiovascular events • Lifestyle management and risk factor mitigation